Related Experiment Video
Updated: Jun 22, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
A systematic review of neuropsychiatric symptoms in mild cognitive impairment
Roberto Monastero1, Francesca Mangialasche, Cecilia Camarda
1Section of Neurology, Department of Clinical Neuroscience, Laboratory of Epidemiology and Psychology of Aging and Dementia, University of Palermo, Palermo, Italy. roberto.monastero@unipa.it
Abstract:
Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common behavioral symptoms were depression, anxiety, and irritability. Hospital-based samples reported a higher global prevalence of NPS than population-based studies; this discrepancy probably reflected differences in demographics, study setting, MCI diagnostic criteria, and behavioral instruments used. Prospective studies showed that NPS, particularly depression, may represent risk factors for MCI or predictors for the conversion of MCI to Alzheimer's disease (AD). NPS are very prevalent in subjects with MCI, displaying a similar pattern of symptoms compared to dementia and AD. Large cohort studies using standardized MCI criteria and behavioral instruments are required to evaluate the prognostic role of NPS in MCI.
Insights
Neuropsychiatric symptoms (NPS) are common in mild cognitive impairment (MCI), affecting 35-85% of individuals. These symptoms, like depression, may predict progression to Alzheimer's disease.
Area of Science:
- Neurology
- Geriatrics
- Psychiatry
Background:
- Mild cognitive impairment (MCI) represents an intermediate stage between normal aging and dementia.
- MCI is characterized by heterogeneity in clinical presentation, etiology, and prognosis.
- Neuropsychiatric symptoms (NPS) are increasingly recognized in MCI populations.
Purpose of the Study:
- To systematically review the prevalence and features of NPS in individuals with MCI.
- To explore the potential role of NPS as risk factors or predictors for MCI progression.
Main Methods:
- Systematic literature search of the PubMed database up to August 31, 2008.
- Inclusion of articles with strict selection criteria and duplicate outcome variable extraction.
- Analysis of 27 included articles, with 14 utilizing prospective cohorts.
Main Results:
- Global prevalence of NPS in MCI ranged widely from 35% to 85%.
- Depression, anxiety, and irritability were the most frequently observed behavioral symptoms.
- Hospital-based studies reported higher NPS prevalence than population-based studies, likely due to methodological differences.
Conclusions:
- NPS are highly prevalent in MCI, mirroring patterns seen in dementia and Alzheimer's disease (AD).
- NPS, particularly depression, may serve as risk factors for MCI or predictors of conversion to AD.
- Further large cohort studies with standardized criteria are needed to clarify the prognostic significance of NPS in MCI.
More Related Videos
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction

